StockData
BFNHOTCLaboratory Analytical InstrumentsFiscal year ends December 31

BIOFORCE NANOSCIENCES HOLDINGS, INC.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$6.87−0.04 (-0.58%)

Close on Oct 19, 2026

Market cap
$230.52M
P/E (TTM)
687.2
Dividend yield
–

BIOFORCE NANOSCIENCES HOLDINGS, INC. revenue by segment

No segment breakdown reported

Bioforce Nanosciences does not break out revenue by segment, region or product in the tagged data of its filings for this period type.